Fornebu, July 17, 2026 - Reference is made to the announced merger between Aker BioMarine ASA (Aker BioMarine) and an indirect subsidiary of Aker ASA (Aker) announced on July 16, 2026 (the Merger).
As previously announced, shareholders in Aker BioMarine (other than Aker's subsidiary Aker Capital AS) will upon completion of the Merger receive merger consideration as a combination of cash and shares in Aker. TRG Holding AS (TRG), Aker's largest shareholder, has today agreed to lend to Aker up to 1,383,892 shares in Aker to facilitate settlement of the consideration shares in the Merger. The number of shares borrowed will be reduced with the number of treasury shares held by Aker at the time the Merger is completed that can be used as settlement in the Merger. Any shares borrowed shall be redelivered no later than December 31, 2026.
This information is subject to the disclosure requirements pursuant to Article 19 of Regulation EU 596/2014 (the EU Market Abuse Regulation). Please refer to the attached PDMR Form for further details.
Atle Kigen, Head of Media Relations and Public Affairs +47 90 78 48 78
Fredrik Berge, Head of Investor Relations +47 45 03 20 90
This information has been submitted pursuant to the Securities Trading Act § 5-12 and MAR. The information was submitted for publication, through the agency of the contact persons set out above, at 2026-07-17 17:27 CEST.